Fig. 2 | International Journal of Oral Science

Fig. 2

From: The osteogenesis of Ginsenoside Rb1 incorporated silk/micro-nano hydroxyapatite/sodium alginate composite scaffolds for calvarial defect

Fig. 2

Gene expression of osteogenesis markers and ALP activity in BMSCs treated with ginsenoside Rb1. a–f Realtime PCR assay of Runx2, ALP, OPN, OCN, VEGF, and ANG 1 mRNAs in BMSCs exposed to ginsenoside (*in contrast to 0 μmol·L−1 at every temporal point). g, h ALP staining and ALP activity quantitative results after treatment with ginsenoside for 7 days (*in contrast to 0 μmol·L−1 group, *P < 0.05, n = 3)

Back to article page